These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9056594)

  • 21. The subject-by-formulation interaction in multivariate bioequivalence.
    Cao L; Mathew T
    J Biopharm Stat; 2007; 17(3):367-79. PubMed ID: 17479387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on the statistical analysis of bioequivalence studies.
    Steinijans VW; Hauschke D
    Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S45-50. PubMed ID: 1601531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioequivalence revisited: non-parametric analysis of two-period cross-over studies.
    Wijnand HP
    Comput Methods Programs Biomed; 1993 Aug; 40(4):249-59. PubMed ID: 8261772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal sampling times in bioequivalence tests.
    Kong FH; Gonin R
    J Biopharm Stat; 2000 Feb; 10(1):31-44. PubMed ID: 10709799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Robustness and power of analysis of covariance applied to data distorted from normality by floor effects: homogeneous regression slopes.
    Sullivan LM; D'Agostino RB
    Stat Med; 1996 Mar; 15(5):477-96. PubMed ID: 8668873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative bioavailability of two tablet formulations of ranitidine hydrochloride in healthy volunteers.
    Bawazir SA; Gouda MW; El-Sayed YM; Al-Khamis KI; Al-Yamani MJ; Niazy EM; Al-Rashood KA
    Int J Clin Pharmacol Ther; 1998 May; 36(5):270-4. PubMed ID: 9629991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioequivalence of two commercial preparations of trimethoprim/sulfamethoxazole: a randomized, single-dose, single-blind, crossover trial.
    Alonso Campero R; Bernardo Escudero R; Del Cisne Valle Alvarez D; González de la Parra M; Namur Montalvo S; Burke Fraga V; Silva Hernandez R; De Lago Acosta A
    Clin Ther; 2007 Feb; 29(2):326-33. PubMed ID: 17472824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A modified large sample approach in the assessment of population bioequivalence.
    Quiroz J; Ting N; Wei GC; Burdick RK
    J Biopharm Stat; 2000 Nov; 10(4):527-44. PubMed ID: 11104391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trimmed weighted Simes' test for two one-sided hypotheses with arbitrarily correlated test statistics.
    Brannath W; Bretz F; Maurer W; Sarkar S
    Biom J; 2009 Dec; 51(6):885-98. PubMed ID: 20014203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative bioavailability of two tablet formulations of acyclovir in healthy volunteers.
    Al-Yamani MJ; Al-Khamis KI; El-Sayed YM; Bawazir SA; Al-Rashood KA; Gouda MW
    Int J Clin Pharmacol Ther; 1998 Apr; 36(4):222-6. PubMed ID: 9587049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative bioavailability of two tablet formulations of metoclopramide hydrochloride.
    el-Sayed YM; Niazy EM; al-Rayes S; Ismail AO; Gouda MW
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):136-9. PubMed ID: 7599911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple testing for bioequivalence with pharmacokinetic data in 2 x 2 crossover designs.
    Chen YI; Huang CS
    Stat Med; 2009 Dec; 28(28):3567-79. PubMed ID: 19760611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative bioavailability of two tablet formulations of ibuprofen.
    el-Sayed YM; Gouda MW; al-Khamis KI; al-Meshal MA; al-Dhawailie AA; al-Rayes S; Bin-Salih SA; al-Rashood KA
    Int J Clin Pharmacol Ther; 1995 May; 33(5):294-8. PubMed ID: 7655769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innovative Design and Analysis for PK/PD Biosimilar Bridging Studies with Multiple References.
    Song F; Zheng X; Wang Y; Chow SC; Sun H
    AAPS J; 2021 Nov; 24(1):3. PubMed ID: 34850298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tests of equivalence and non-inferiority for diagnostic accuracy based on the paired areas under ROC curves.
    Liu JP; Ma MC; Wu CY; Tai JY
    Stat Med; 2006 Apr; 25(7):1219-38. PubMed ID: 16158400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of an HPLC method for determination of diphenidol in plasma and its application in an oral multi-dose bioequivalence study in a healthy female Mexican population.
    Hernández J; Marcelín-Jiménez G; Rivera L; Alionka PA; Contreras L; Hinojosa M; Martínez-Rossier L; Amancio O; Fernández A
    J Pharm Biomed Anal; 2005 Jul; 38(4):746-50. PubMed ID: 15967303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioequivalence and intrasubject variability.
    Liu JP
    J Biopharm Stat; 1991; 1(2):205-19. PubMed ID: 1844697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computer simulations of bioequivalence trials: selection of design and analyte in BCS drugs with first-pass hepatic metabolism: linear kinetics (I).
    Fernández-Teruel C; Nalda Molina R; González-Alvarez I; Navarro-Fontestad C; García-Arieta A; Casabó VG; Bermejo M
    Eur J Pharm Sci; 2009 Jan; 36(1):137-46. PubMed ID: 19028574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Review and use of decision rules for bioequivalence trials].
    Nicolas P; Tod M; Petitjean O
    Therapie; 1993; 48(1):15-22. PubMed ID: 8356540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, open-label pharmacokinetic comparison of two oral formulations of fluconazole 150 mg in healthy adult volunteers.
    Jovanović D; Kilibarda V; Cirić B; Vucinić S; Srnić D; Vehabović M; Potogija N
    Clin Ther; 2005 Oct; 27(10):1588-95. PubMed ID: 16330294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.